Atopic Dermatitis
📧 Sign up to get email alerts when something new happens for Atopic Dermatitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-09-22Clinical Trial Update: A Phase 3 Study of MH004 Ointment in Patients With Mild to Moderate Atopic Dermatitis [Phase 3]
A Phase 3 clinical trial evaluating MH004 Ointment for mild to moderate atopic dermatitis has completed.
-
CLINICAL_TRIALS trial_result · 2025-09-19Clinical Trial Update: Safety and Tolerability of BSI-045B in Healthy Adult Subjects and Patients With Atopic Dermatitis [Phase 1]
Phase 1 safety and tolerability data for BSI-045B in healthy adults and patients with atopic dermatitis are presented.
-
CLINICAL_TRIALS trial_result · 2025-09-19Clinical Trial Update: MH004 Ointment in Healthy Adult Volunteers and Participants With Mild to Moderate Atopic Dermatitis [Phase 1, Phase 2]
Clinical trial update for MH004 Ointment in healthy volunteers and adults with mild to moderate atopic dermatitis, covering Phase 1 and Phas…
-
CLINICAL_TRIALS trial_result · 2025-09-18Clinical Trial Update: A Study of the Effects of Camoteskimab in Adults With Moderate to Severe Atopic Dermatitis [Phase 2]
Phase 2 study evaluating camoteskimab in adults with moderate to severe atopic dermatitis has completed.
-
CLINICAL_TRIALS trial_result · 2025-09-15Clinical Trial Update: Dupilumab Skin BArrier Function and LIpidomics STudy in Atopic Dermatitis in China [Phase 4]
A Phase 4 clinical trial evaluating dupilumab in Chinese patients with atopic dermatitis has completed, focusing on skin barrier function an…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-09-11Clinical Trial Update: Efficacy and Safety Study of SHR-1819 Injection in Adult Patients With Severe Atopic Dermatitis [Phase 3]
A Phase 3 clinical trial evaluating SHR-1819 for efficacy and safety in adults with severe atopic dermatitis is active but not recruiting.
-
CLINICAL_TRIALS trial_result · 2025-09-11Clinical Trial Update: Staphylococcus Aureus in Atopic Dermatitis Immunopathology [NA]
A completed clinical trial investigating the role of Staphylococcus aureus in the immunopathology of Atopic Dermatitis.
-
CLINICAL_TRIALS trial_result · 2025-09-10Clinical Trial Update: Evaluation of the Effect of the Product RV4660C CY0203 on Clinical, Biometrological and Biological Parameters in Adults With Mild to Moderate Atopic Dermatitis, an Exploratory Study
This exploratory clinical trial evaluates the effects of RV4660C CY0203 on clinical, biometric and biological parameters in adults with mild…
-
CLINICAL_TRIALS trial_result · 2025-09-05Clinical Trial Update: Maximal Use Study of Tapinarof Cream, 1% in Pediatric Subjects With Extensive Atopic Dermatitis [Phase 2]
Phase 2 maximal-use study results for Tapinarof Cream 1% in pediatric patients with extensive atopic dermatitis have been posted.
-
CLINICAL_TRIALS trial_result · 2025-09-04Clinical Trial Update: Tapinarof for the Treatment of Atopic Dermatitis in Children and Adults [Phase 3]
A Phase 3 trial evaluating tapinarof for atopic dermatitis in children and adults has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2025-09-02Clinical Trial Update: Efficacy and Safety of Roflumilast Cream in Subjects With Atopic Dermatitis [Phase 3]
Phase 3 clinical trial results evaluating the efficacy and safety of roflumilast cream in Atopic Dermatitis have been completed.
-
CLINICAL_TRIALS trial_result · 2025-09-02Clinical Trial Update: Tapinarof for the Treatment of Atopic Dermatitis in Children and Adults (DMVT-505-3102) [Phase 3]
Organon announced the completion of a Phase 3 trial evaluating tapinarof for atopic dermatitis in children and adults, with results posted o…
-
CLINICAL_TRIALS trial_result · 2025-09-02Clinical Trial Update: A First In Human (FIH) Study of IBI356 in Healthy Participants and in Atopic Dermatitis Patients [Phase 1]
This document announces the completion of a first-in-human Phase 1 study of IBI356 in healthy participants and in patients with atopic derma…
-
CLINICAL_TRIALS trial_result · 2025-08-29Clinical Trial Update: To Demonstrate the Superiority of IMP (1% OPA-15406 Ointment) to the Vehicle in Adult Patients With AD [Phase 3]
Phase 3 trial of 1% OPA-15406 ointment in adults with atopic dermatitis demonstrated superiority to vehicle.
-
CLINICAL_TRIALS trial_result · 2025-08-28Clinical Trial Update: Evaluation of the Efficacy of a Dermocosmetic Product RT00401-GO0046 on Atopic Dermititis Severity in Subjects With Mild Atopic Dermatitis Versus Placebo
A completed clinical trial evaluating the efficacy of a dermocosmetic product RT00401-GO0046 for reducing atopic dermatitis severity versus …
-
CLINICAL_TRIALS trial_result · 2025-08-27Clinical Trial Update: Social Media Follow-up Nursing for Atopic Dermatitis [NA]
Completed clinical trial evaluating social media follow-up nursing for patients with atopic dermatitis.
-
CLINICAL_TRIALS trial_result · 2025-08-24Clinical Trial Update: Phase 2a, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability, and Pharmacodynamics of EP262 in Subjects With Atopic Dermatitis [Phase 2]
EP262's Phase 2a randomized, double-blind, placebo-controlled study in subjects with atopic dermatitis has completed, with results posted an…
-
CLINICAL_TRIALS trial_result · 2025-08-22Clinical Trial Update: Effect of Benralizumab in Atopic Dermatitis [Phase 2]
Phase 2 clinical trial evaluating benralizumab for atopic dermatitis has completed and posted results.
-
CLINICAL_TRIALS trial_result · 2025-08-19Clinical Trial Update: An Observational Study of Upadacitinib to Assess Change in Disease Activity in Canadian Adult Participants With Moderate-to-Severe Atopic Dermatitis Who Are Inadequate Responders To or Discontinuing Dupilumab
A completed observational Canadian study assessed changes in disease activity in adults with moderate-to-severe atopic dermatitis who inadeq…
-
CLINICAL_TRIALS trial_result · 2025-08-15Clinical Trial Update: A Study to Evaluate the Quality of Life of Male and Female Adult Patients With Severe Refractory Atopic Dermatitis Treated With Dupilumab in Czech Republic
This completed study evaluated quality of life outcomes in adult patients with severe refractory atopic dermatitis treated with dupilumab in…
-
CLINICAL_TRIALS trial_result · 2025-08-15Clinical Trial Update: A Community-based Assessment of Skin Care, Allergies, and Eczema [NA]
A community-based clinical study evaluating skin care, allergies, and eczema in individuals with atopic conditions; results have been posted…
-
CLINICAL_TRIALS trial_result · 2025-08-14Clinical Trial Update: A Study to Assess Real-World Use, Safety, and Effectiveness of Oral Upadacitinib in Adult and Adolescent (>=12 Years Old) Participants With Atopic Dermatitis
Clinical trial update describing real-world use, safety, and effectiveness of oral upadacitinib in adults and adolescents (≥12 years) with a…
-
CLINICAL_TRIALS trial_result · 2025-08-14Clinical Trial Update: Topical ENS-002 for Atopic Dermatitis in Adults [Phase 1]
Concerto Biosciences reports termination of its Phase 1 trial of topical ENS-002 for adults with atopic dermatitis.
-
CLINICAL_TRIALS trial_result · 2025-08-13Clinical Trial Update: Long Term Extension Study of Tapinarof Cream, 1% for Subjects With Atopic Dermatitis [Phase 3]
Phase 3 long-term extension study of Tapinarof 1% cream for atopic dermatitis has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2025-08-08Clinical Trial Update: Efficacy of Jelly Fig (Ficus Awkeotsang Makino) Extract for Atopic Dermatitis [Phase 1]
Phase 1 trial evaluating Jelly Fig Extract (Ficus Awkeotsang Makino) for atopic dermatitis has completed. Sponsor: Kaohsiung Veterans Genera…